Abstract
Mos t o f t he 2022 mpox outbr ea k s in high incom e coun t ri es , w hich pr e domina ntl y affec ted men wh o
have sex w ith men, p eake d l es s tha n two months a f ter d etec t io n . To st op the ou tbrea k s , pe ople
we r e encou r a ged t o li mit new s ex partn e rs , tak e up a ny o ff er s f or s mal lpox vacc ination , a nd s elf -
isola te . The rela t i ve c ont r ib ut i o n s of e ac h of th ese s tr ategi e s to ou tbre ak reduc ti on are ha rd to
kno w. To conside r the p o t e n t i al r elative ef fic acy of eac h o f th e se mea s u re s indivi dually , we
co nstruct ed a gen t-b a sed mode l s u s ing pl ausibl e par t n e r s hip c ount s , r e a s on able b e havio ur choic e s
and publi shed in forma tion ab out smallp ox va cci nation uptak e r ate s in the UK c o ntext during 2022.
Compa red to a b as eli ne , no in te r venti on scen a r io , pa rtn er re duction w a s mor e ef f ec t i v e at
preve nt i ng ge n era tion o f second a r y ca se s th an the vac cine ro llout at th e spee d t h a t t h e s ma llp ox
va cci ne rollout oc cur red in t h e UK in 202 2. Thes e fin di ngs s ug ge st t h at p artn er re d uction by the
most a f fect ed communi t y ra ther t h an ph armac eutic al inte rve nt i on was la r g ely to c redit for ca u s ing
ca s e numb er s t o p eak a s ea rly a s they di d.
Keywords
mpox ; UK; s exual ly tran smit te d infec t i on s ; a g ent -ba s ed-mo del s; sel f -i sola tion ; vacc ines
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
3 | Page
Introduction
Mpox is a smallpox -like zoono tic infec tio n ca us e d by a virus in th e Or t h opoxvi r u s ge nus o rig inally
ende mic i n some ar ea s of Af rica. The mo st co mmon mpox s y mpt oms a r e fever an d
ly mphadenop a thy wi t h many persi ste nt and pote ntia lly very pa in ful le sion s . Rec o v ery t y pica lly tak es
2-4 w eek s an d con fer s long -l a s ti ng immunity t o r e in fec tion . Tran s mi ssi on to huma ns occu rs a ft er
phy s ic al c ont act w ith an i n f e cti ou s individual, contami n at ed mate rial s or a n a nima l
1 . The historic
ca s e fa tality ra te wa s th ought to b e abou t 10% , and w as know n to b e hi gher in c hi ldren a nd low e st
in h ealthy a dul t s
2 . Although no vac cin e has b een devel oped ag ain s t mpox spec i fi ca lly, smal lpox
va cci nes have high e ff i c ac y ag ains t mpox, r ed ucing di sea se ac qui s i t i on by a bou t 8 0% afte r one or
two d ose s 3,4 . I t is thoug ht t h at p rote ctio n from th e smal l pox vacc ination may de c line ov er time , but
only s l owly 5 . That c es sation o f ro ut i n e co mmunity vacc ination a gain st smallp ox might l ead to
recurring mpox ou t b rea k s wa s sugge s ted 5 .
Historic ally , mo st mpox outb reak s wer e quic kly contai ned an d s e e med to inv olve r e lativel y short
tran s m i ssion c hain s (u nder 7 gen era tion s befor e out bre ak end 2 . H ow ever, a la rge number of mpox
ca s e s in n ew c ountri es a nd c ontin ent s w ere ide nt i f i ed in 2 022, c au sing f ea rs t hat the di s ea se m ight
bec ome en d emic in many new r e gions . The 2022 m ulti-coun try ou t b rea k ove r w helming ly a f f e cted
men who ha ve sex with men ( M S M ) s 6 . Mos t ho spit ali sati on s in hig h inc ome c ou nt rie s in 2022 w ere
due t o ne ed f or ana lg esic re lie f 6,7 , a nd relatively fe w dea ths w e re a s s oc ia ted w it h the 202 2 multi -
co untr y outb r e ak s 8 . A mode st ob served ca s e fa ta lity ra te ( CF R , probably < 1% ) in 202 2 is thought to
relat e i n par t to the speci fi c (mild e r ) c lad e 3 vi r use s t hat the 202 2 out break c a se s mos tly have 9 , a s
we ll as und er -a sce rtain me nt o f ca se s whe r e mpox was t r a di tionall y end e mic w hich may h ave
skew ed hi s tor ic al e stimat e s of the C FR. Howe ver, to p reve n t onward di s e a se tr a nsmi s s ion , eve n
non-ho spi tali s ed c as e s were s tr ong ly a dvised i f no t a l s o lega lly requi r e d t o stric tly s e l f -i s ola t e f or a
minim um of thre e we ek s, ca u s i ng ec ono mic and soci al di srup tion for t ho s e a ff ect ed.
Mos t o f t he 2022 mpox ou t br ea k s in high incom e coun t ri es p ea ked l ess than tw o months a f t e r
detec t i on. To br i ng t he ou tbre ak s und er control, M S Ms w er e e nco ur a ge d to li mit new s ex par tne rs,
to take the smallpox vac ci nation , an d to s e l f - i s ola t e if they k new t he y had t h e vir us. The r ela tive
co nt ribu tion s o f e ach o f t he se stra tegi es to outb reak r eductio n are ha rd to k now. Co nt a c t tr acing
wa s e xpec te d to b e c halle nging beca u se of pr i vac y w or rie s, r ela tiv ely high in ciden c e of a nonymou s
p a ir i ng s an d so c i al s t i gm a
10 , mak ing i t d ifficul t to find peo ple who ne e ded t o be warned to b e
v i gilant a nd s eek t es ting i f t he y had r e levan t symptom s. I n pa rt beca use o f limite d smal lpox vacc ine
suppli e s, va cc ination p rog r a mme s in mo st s e tti ngs w ere not o f fer ed univ ersal ly a nd instea d ini tia lly
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
4 | Page
targe ted MS M s thoug ht to be a t grea t e s t ris k of in fec tion du e to beh avi our a l hi s to r y . Pa r t ner
reduc t i o n and vacc ination p r og r a mme s h ad a ppar ent s u cce ss, in th at b y mid Aug u s t 20 22, ab ou t
50% of America n MS Ms r e po rt e d r e duc ti ons in t hei r sex ual a c tivity t o pre vent c at ching mpox 11 , and
by mid-N o vember 20 22 t ake up o f the s mallp ox v acc ine a mong el igible U K-r esi d ent MSM s wa s ne a r
50% 4 . The level of ad here nce t o self -i so lation guida nc e ha s b een h arde r to a s c e rtai n. Se l f -i s ola t i on
for pe r s o n s w ith con fi r me d in fec tion or susp ec t e d exposu re w a s encour ag ed ( for i nsta nce, in B ritain
from 22 Ma y 2022 12 ) b ut not leg al ly req uired in many jurisdic tion s.
Never thel es s , it seem s like ly tha t be h aviour c hange s (p a r tn er r educ tion and complia nce with
gui dance to s e l f - i s ola te ) a s well a s vac cin a t i on pr ogramme s all cont ribut ed to ou t break red uction .
To c onside r the p ote ntia l r ela tive e ffica c y o f each of the se mea sur es in i sol ation , w e c ons t ruct ed
a ge n t- bas ed m o de ls
13 for mpox tran smi s s ion among MS Ms u sing plau si ble par t ne r ship c ou nt s ,
rea sona ble beh aviour choi ce s and v ac cin ation up take r a t e s . Th e finding s w er e u s ed to sugge st whi ch
of th ree c ommon mpox co nt r ol stra tegie s may have made th e grea te s t contrib uti on to e a rly
sub s i d ence o f the ou tbr eak. Sen si tivi t y a nal ys i s w a s under taken by v arying the m ost unc er tain
epid emiolog ical pa rame ter s.
Methods
Overview
Bas eline a nd a lt er n a tive sc e nari o s were c onstruct ed within a gen t ba sed mo d el s (ABM s) u sing
Netl ogo ver s ion 6.0.2 . Agen ts in the mo de ls h ad fou r po s s ibl e sta tes tha t oc curre d in t hi s se quenc e :
su s c ep tible –e xpo sed −inf ec t ed−r eco ver e d (reco ve red = immune ; S EIR) . All of o ur s i mulati on s
co ns id e r t h e cas e o f 6 400 ag ent s w ho ar e a ll MSM s, wi t h no n ew member s adde d or depar ting
during each s im ulatio n (a clo sed sy ste m). We us ed a popula tion o f 6400 a gent s in order t o be a bl e
to ge nera te many s i mula tion r es ult s i n a rea sona bl e tim e fr ame ( l a rger age n t cou nts woul d h ave
take n much longer to a chieve mod e lling re sult s ) . O u tc ome s ar e alw ays moni t or e d from simula ti on
sta r t (w hen c ontrol mea su r e s sta rt to be appl ied ) until ou t bre a k end ( w he n no mo r e age n t s a re
infec ti ou s or incuba t i ng) .
We ide n t i f y plau sibl e par amet er e stim at es an d a s s umption s, sp ecify ing our pr ef e rred e s timat e s and
as s u mp t i on s , trea ting the ado pt i o n of th ese plau sible as s ump tion s a s a ba se line a nd rea sona bly
pla us i bl e s c ena rio. We t h en ex plore wha t happen s i f w e us e alt erna tive credi ble e stima te s o r
as s u mp t i on s i n oth er key epid e miologic parame t e rs . F irst, we con sid er th e p o s it ed control
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
5 | Page
strat eg ie s unde r the b a seli n e con dition s. We als o va r i ed epi de miologi cal and c on tr ol par amet er s , to
as s e ss sen s i tivity to sel ec ted as s ump t io n s .
We c ompar e outb reak cont rol w ith r esp ec t to two h a r mful o utcome s : dura tion a nd number o f n ew
ca s e s . Outb reak du r a ti on is d efin ed a s d ur a tion in h o urs or day s f rom simul a t i on s t art (whe n cont rol
strat eg y sta r t s to be a ppli ed ) un t il th ere are no more inf ectiou s o r inc ubating age n t s (ou tbre ak end) .
Number o f new ca s e s i s de fine d a s the n umber of n e w c ase s tha t o ccur a fte r the s imul a tion st a r t
until o ut b rea k en d. We repo rt ou tcome s aft er 1000 s im ul ation s for th e ba se line sc enario a nd
sugge st ed pla u s i bl e impl ement atio ns of eac h co nt r ol stra tegy. A s sen si tivity anal y s is , w e run 100
itera tion s for al ter native way s o f implem e nt i ng ea ch c on tr ol s t rat egy with v arying assumpti on s
abou t t ran smi s s ion r i s k per con tac t di f fer ent numbe r s of se ed ag en t s . The outco mes do no t
ac count f or ho spit ali sati on s or de a t h s be c aus e we were i nte re sted in s c en ario s w hen most
symptom s were mi ld, mo rtali ty r a te s very low and most ca s e s stay ed in the c om munity, simil a r t o
most o f th e 2022 outb reak s. W e do n o t consid er th e po s s i bility o f a s y mptoma tic tran smis s io n
bec au se it se emed unlike ly; a 2022 a udi t of 2917 s p ec imen s f rom MSM s at ten ding s ex ual h e alth
cl inics in Engla nd fou nd lo w preva lenc e ( 0.14% , n=4) o f no n -symp t oma tic mpo x i nfec ti on
14 . We do
not c on s id er t he po ssibi li ty of ai r born e t r ansmi s s i on b ec au s e o f previou s mod e ls w hic h s ug ges ted
that thi s was li kely to b e rel atively r a re fo r mp ox
15 .
Fully fixed model parameters
ABM s incorpo rat e a blend o f stoch a s tic a nd de t e r mi ni s tic par amet er s. The r e ar e f ixe d
(det ermini s tic) a s pec t s of ou r model s ( s a m e in a ll scen a r io s), pa rtly det ermini st i c an d partly
stoc ha stic pa r a met er s , a s w ell a s e xplic itl y varied pa r a me ter s (fo r s en s i t i v ity a n alysi s).
We full y fix ed a sp ect s o f our mode ll ing e nvironment for pr ag matic re a son s and /o r whe r e t h e e ff ect
of varying the a ssump tion wa s predic t a bl e. F ully fixed a s pe c ts of ou r model s in a ll simulati on s are :
co unt of ag en ts (6400 ) , popul atio n under s tudy ar e al l MSM s an d the sy stem i s c lo s e d : the re ar e no
new member s, no a gen t dep a r tu re s and no new spo radic ca s e in tr odu c tion s. The choic e of 6 400
ag ent s i s not me ant t o be de fi nit ive or a priori know n to be o p t i mal. R ath er, w e u se a f i xed n umber
of ag en t s i n the mod el s to st andardi s e th e sce n ario s rel ative to t h e sen sitiv it y an a l yse s , s uc h th at th e
fac t o r s tha t s eem t o c ause cha nge s in th e p r ima r y outcom e s (dur ation o f th e out break and new ca s e
co unts) should a r i se from varia tion s fu nd amental to th e con t r ol s tra tegie s tried ra ther than
va r i ation s in th e popu l ation size . I t is pr e dicta ble that a l arger po pula ti on woul d h av e poten tial f o r
long er dura tion ou tbr eak , s o we do not u ndert ake sen sitivi ty anal ys i s by vary ing t he tot al number o f
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
6 | Page
ag ent s . 6400 a gen t s fo r the s c en ario s i s also a p rag matic choic e to ena ble ex te n s i ve sen si t i v ity
ana lysi s o f oth er facto r s , and ma ny simul ation s an d mod el s to be gen era ted a nd su mmarise d u s i ng
our availab le re sour c e s within a f ea sible t i mef r a me .
Si milarly, t h e di ff er ence be twee n clo se d a nd open popul atio ns o n ou t b rea k devel opment i s
predic ta ble, a n o pen sys tem (n ew age nts enter an d some age n ts depa r t ) is lik ely to have longer
duratio n a nd more vari able d ev elop men t. An ou tbre ak or epid em ic in a c los e d s y s t em w ill a lway s
co me to an end , a s long as rein fect ion i s not po ssible , as s umi ng t hat n ew s po rad i c c ase s canno t
oc cur. We a l s o con fine d our modelli ng t o ac count f or jus t one k ind o f s exu al par t ner s h ip (me n w ho
have sex w ith men, MS M s ) ; the 2 022 ou t break s in nov el s et ting s overwhelmi ngly s t ay ed withi n thi s
sexua l minori ty c ommunity. Adding oth e r s ex ual pr e fer enc e group s (eg. , wome n who ha ve sex with
men or women w ho hav e s ex w ith men who ha ve sex with men) would h ave a dd ed c omplex ity to
our ow n model s wi t ho u t increa sing in s i g ht into wh ich mp ox c ontr ol s t rat egie s ha d great es t pot enti al
to wo r k well in a pr e domin antly MSM ou tbre ak.
Model assumptions that were mixed deterministic and stochastic
Asp ect s o f the ag ent in ter action e nviron men t h ad fixe d at tr i bu t e s ( such a s medi a n value for entire
popul ati on) bu t the s e val ue s varied f o r i ndividua l ag ent s be t w een sce n ario s , t hu s th e se
environmen tal a nd be havioural m od el a s sumpti on s are p artly de t e rmin istic and p a r tly stoc ha s t i c.
Homophily in sexual contact network
A ke y aspec t of mod el c on st r uc t i on, to m ak e su r e t h e model rep r e s ent ed re a li s tic beha viour c hoice s,
wa s to e stabli s h h om ophily within s oc ial netw or k s . H omo p hily i s th e pr i ncipl e tha t peopl e tend to
socia li se with oth er pe ople li ke th em selve s
16,17 , a nd in this c a se fo r sex ual pa rtner ship ne tw or k s ,
wi t h ot h e r per s on s who have s im ilar s exual appe tite s to one s elf . T o ach ieve hom ophily , one thi rd of
ag ent s w ere l oc at ed at r andom plac e s in the ag en t world. Mo st ( targe t 67% ) age n t s w e r e loca t e d
(s t oc ha s t i call y in individ ual mode l run s) i n 64 c lust e r s with simil ar s ex ual appe tit e s, ini tial ly pla ced on
model deve lopme nt t o follow pr oximi t y and d en s i t y rul es u se d in au t h or s’ pr evio u s AB M s 18 t o
ac hieve conta c t rat e s and r elati on ship co ntac t simil ar t o tho se r ep o r t ed fo r th e UK i n obser v a tional
re sea rch 17,19 . A gamma dist ribution wa s used for exp ected sex act di stribu tion, c or re spo nding with
the ‘h e avy t a il’ ob se rved in s ome MSM s exu al c ont a ct n etw or k s 15 .
How stro ng homophi ly (on sex ual a p peti te dimen sion ) i s w ithin th e MSM commu nity was no t
fea sibl e fo r u s to pa r a met eri se with emp i r ic al data , rat her we cr eat ed varie ty i n homophil y
(simil arity f or i ndividua l ag e nt s w ith ot he rs i n t heir con ta ct ci r c le s ) t h a t wa s plau si ble . Clu s ter s ha d
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
7 | Page
dime ns i on s tha t w ere ap proxi mat ely 12.2 dist anc e unit s diam et er. The med i an n umbe r of ag ent s
wi t hi n a 6.1 radiu s o f eac h ag ent wa s ab ou t 144 in m ost mode l run s (rang e appro x imately 42-242).
Within thi s 6 .1 rad iu s circle , abou t 67 % of ag ent s h ad an averag e of h alf o f t h e ir c ontac t s w ith s i milar
sexua l app eti te s; remain ing ag en t s w ithi n 6.1 dis t a nce u ni ts ha d a di ver s i ty (stoc h astic ally plac ed ) of
sexua l app eti te s . In t hi s w ay, some agen ts ended up wi t h high hom op hily in their loc al a r ea ; oth er s
had high variation i n s e xual ap peti te / lo w homophily among their s o cial cont ac ts . U ltima te ly, w e
as s e ss ed th e pe rforma nc e of o ur mod el s and ag ent s ’ b ehavi our within o ur model s, aga in st
pre speci fi ed an d p lau sible targe t s abou t ho w many unique partn er s a nd uniqu e sex ac t s t hat a g ent s
typic ally exp er i ence d in mod e l run s (s ee T able 1).
Calibration and partner seeking behaviour
Anoth er impor tan t obje ctive o f the cl u st er plac emen t a nd indic a tor s that the mo dels we re
repr ese nti ng pa r tn er ship be ha viour a s in tende d, wa s to e n s u re th at mo st ag e nts ha d low part n e r
co unts (≤ 1 ove r a t h ree wee k moni torin g period), and t ha t mo s t sex act s wer e w ith a l imited
numbe r o f ot h e r agen t s, re s ul t i ng in the pr e s pec i fied ta r g e t count s o f unique sex ac ts an d unique
partn er s (se e Table 1 ). D en sity of ag ent plac ement a n d di st a nc e s move d eac h ho ur (wh en th ey
co uld pla usibl y enc ount er new agen t s) , a s wel l a s s e arch radiu s f rom w hich to sel e ct a po ten t i a l
partn er, w ere empiric ally cal ibra te d in mode l developm ent, a s a functi on of sex ual a ppeti te.
Adjus tment o f t r a vel and se arch d i s tanc e s allow ing fo r sexua l appe t i te was to en s ure tha t th e s exua l
ac tivity (i n te r m s of un iqu e sex a ct s and pa r tn er c ount s) o f a gent s fell on the ta r g et di st ri butio n over
3 w eek period s (me dian p ar t ne r c ount = 1 , media n se x ac t s = 3-6 ), and tha t high er uniq ue par tner
and sex ac t count s would r e s ul t f or th e a gent s with hig he st sex app etit e. The mo de ls h ad a f u rth er
targe t tha t th e ma ximum s ex ac ts ac hieved sh ould te nd t o hav e medi an abou t 32 a cts/we ek, a nd
uniqu e par tne r count w ith medi a n max imum ≤ 24. T hese t arge t s guiding model develo pmen t and
ca librati on a r e me ant to be plau sibl e n ot defini tive . The t a r g et for me dian ( 1 ) uni que p artner c oun t s
wa s c ho sen wi t h ref e renc e to em pirical U K data c ollec te d abou t pa rtne r c ount s o ver thr e e wee k
period s, w hich d a ta ove rsampl e d from MSMs u s ing digi ta l appli ca tion s de signe d to faci li tat e ca s ua l
sexua l enc ount ers, in Augu st-S e pte mber 2022
20 .
For c ompari son, 53% o f 5193 America n MSMs in 2009 re ported tha t t h ey ha d s e x wi t h a male
partn er le s s o fte n than o nc e every th ree we eks, whi le 14 .1 % repor ted h aving sex with a noth er male
at le a st twi ce a wee k. W e thought i t w a s pref e r a bl e tha t ag en ts i n o ur model s w e r e cal ibra te d to
be m or e s ex uall y ac t i ve th an t h e gene ra l popula t i on of MS M s , beca u se we w ante d to in clude more
hig h ris k individual s, and t h u s our a ge nt s had targe t s of medi a n 3-6 sexu al ac t s pe r 3 week
monitoring pe riod.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
8 | Page
All a gent s re t ur n to a ‘h ome’ loca tio n a t end o f each 16 hour w aking period , thi s l ea d s t o highe r
co nt a ct r ate s with the same ag ent s . A ma jor i t y of ag e nt s ( targe t 6 0-70% ) ha ve a sing le pre fer red
partn er who is in cl o se pr ox imity t o hom e-loc a tion (within 1.48 di s t anc e uni ts o f home locatio n), t he
“ste ady ”, a nd thu s s houl d be en count er e d oft en. The t arge t (60 - 7 0%) c or r es pond ed with an
obs erved 6 6% (106 / 161 ) MSM s survey ed from th e ge ner al popu la tion w ho re por ted havi ng a
partn er in a public ly a vail able d ata se t o f gay, bisexual and o the r MSM s sur v eye d i n Se pt e mb er 2022
21 .
Eac h w aking hour (16x/day ) eac h in fec t i o us a gen t i s queri ed fo r t h e ir willi ngne s s to have sex , whi ch
wi llingne ss i s a func tion o f th eir fix ed sex ua l appe tite a ttribut e. Empiric ally, th e model s are d e s ig ned
such th at th e median numb er o f s ex a ct s in a thre e w eek perio d sh ould be 4 -6 an d t he media n
numbe r o f unique pa r tn er s (du ring the in fecti ou s perio d, whic h als o ha s medi an d uration o f ab out
thre e w eek s
15 ) s h ou ld u s ua l l y b e 1 . M os t age n ts s tr o n g l y p r e f e r t o h a ve s e x w i th t h e ir s te a d y i f
they have one , rat her than o ther pa r tn er s who might be avai labl e. The st eady do es no t cha nge
during t he pe riod w hen an agent i s in fe ct ious . The stea d y relati on ship i s 10 0% rec iprocal , bu t the
inc lination to have more than on e conc u r ren t pa rtner , to se ek partn er s i n addi tio n t o t he stea dy
(“st r a y. thre s h old”) i s not r ec iprocal . The population me dian str ay.th re shold wa s se t to ab o ut 11%.
Tha t t hr e shold % wa s d e t e rmin ed empi ri c ally to creat e severa l targ et mode l ou tc ome s: tha t > 50%
of al l s e xual act s for all p erson s who have a s t e ady, shoul d be wi t h t h e ste a dy; th at ma ximum
partn er co unt (for a ny ind ividua l age n t ) d ur i ng infec tiou s pe riod should ≤ 24 and maximu m s e x ac ts
during infec tiou s pe riod be ≤ 3 2 .
Duration of period when infectious
Mos t source s a gr ee that the in fe cti ou s p eriod (w hich e n ds whe n sca b s h ave ful ly dried and dr opped
of f) t end s to h ave 2-4 w eek du ratio n af te r s y mptom on s et 15,22 . U S A CD C guida nc e i s t hat sca b s form
on da ys 7 -14 da ys o f mpox illne ss and te nd to ta ke abo ut a we ek to c r u st ove r a n d sta r t d roppin g o ff,
but inf ec tiou sn e ss is no t c on s ide r e d like l y to ha ve e nded un til ski n has comp l et el y he aled over a ft er
the sca b f ell of f 23 . Mpox pati ent s have t es t ed po s i t ive on P CR a s la te a s da y 39 of illnes s 24 .
However, P CR c on firm s pre s enc e o f at le ast s ome viral D NA f r a gmen ts r a t h e r tha n confirm s tha t th e
DN A i s a c tiva t e d (can r e plica te and i s the ref ore in fec tiou s); t e sting po s itiv e on PC R aft er th e
infec ti ou s peri od ha s end e d is common
25 . W i t h t h e se dat a in m ind, simil a r to o th e r mo del s 15 , we
as s u med tha t the in fe c tiou s pe riod ha d media n dura tion 21 day s (504 h ours ), wi th r a nge 14 -28 day s .
The infec tiou s pe r i od fo r indivi dual a gen t s i s s tocha stic within tha t ran ge , w ith a G aus s i a n
dist r i buti on aro und th e median. Full im munity fol low s af te r inf ec t i ou s p e r i od fin ishe s .
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
9 | Page
Daily contact cycles
Model s al way s s tar t a t b eginn ing of da y ( nomina lly 7am) wi t h 16 ac tive ho urs c on s id e r e d for di s e a s e
tran s m i ssion opp o r tuni tie s, thi s mea n s t he maximu m number of sex act s per d ay that coul d h appe n
is 16. To c onfi r m t h a t model s we r e con s tr uc t ed a s sp ecifi e d, we monit ore d s ever al parame ter s s uc h
as how many unique p a r tn e rs and uniqu e s ex acts wer e t y pica lly a chie ved by inf e c t io u s a gent s
during t he ir in fec tiou s pe riod ( approxim a t e ly thr ee w e eks ).
Epidemiologic assumptions varied in sensitivity analysis
We unde r took s en si tivi t y ana ly si s v arying s om e model a ssump tion s and e ach of th e con t rol s tr a t e gy
option s. I n our ba se line p lau sibl e mod el at simul atio n star t, th e numb er o f in fect ed agent s (able t o
tran s m it di se a s e t o oth er s ) numb e r e d 16, w hich could corre s po nd t o a de tec t ed c ase count o f 8 and
undet ec ted c a ses n umb er i ng 8. A s a l t e rna t i ve sta rt poin t s fo r outb reak con trol, w e c ons i de r e d the
ca s e o f 8, 32 or 64 initi a lly i nfec ted a ge nt s in sen s i t i vi ty a nalysi s . Rema ining agen t s were a ssum ed to
be su sce ptibl e with n o rel eva nt vac cina t i on his t o r y .
The r e al ri sk o f mpox tran s mi s si on pe r s e x act (or per type of s ex a ct) i s unknow n. Ea r l y (data
co llec t e d 1981 -198 6) e stim at e s o f s ec o n dary a t t ac k rate s (SAR ) f or mpox were a s l ow as 3%
26 .
However, mpox SAR e stima ted sinc e 201 5 f o r p e r s on s in s ame h ou s eh o ld s with in de x c as e s ( not
nec e ssarily be twee n s e xual pa rtn ers) h ave bee n much higher , 50 -60%
27,28 . In s e n s itivity an a lysi s to
se e if fin ding s abou t c ontrol stra tegie s w ere de pend e nt on the t ran smi s s ion ri sk a ssumpti on s, we
co ns id e r six fixed tr a n s mi s s i on ri s k s ( pe r sex ual e nc ount er) : 6%, 12%, 24%, 36%, 48% a nd 60%. In
our pre fe rred b as eline mod el we ap ply t he e xpec ta tion th at t her e w as a 24% ri s k of tra n s mi ssi on
eac h s ex a ct fr om infec tiou s t o s u scep t ib l e. Our model s d on’ t all ow for vari ation i n tr a n s mi s sion ri sk
that may dep en d on speci fi c s exua l ac ts.
Control Strategies
Three fu ndamen tal con trol strat eg ie s ar e com pared. Ea ch c ont rol s tr at egy wa s c onsid ered
indi vidual ly (not in combin a tion wi t h o t h e r contr ol s t ra teg ie s). The c on trol s t rat e gi es w er e
desc ribed and a pplied w ith va r i a t i on s for sen si tivity analy s i s in a ss es s ing t heir inh erit po ten tia l . It
wa s o bviou s tha t co mbined s tr a t e gie s w oul d be more e ffe c tive t ha n any s t rat egy in isola tion s o w e
did not gene rat e mo del s to de scribe the o bvious adv an tage s o f de ploying multipl e control s tr a teg ie s
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
10 | Page
in c ombina t i on . Rath er, ou r int ere s t was in consid ering plau sible i n dividua l pot ent ial of eac h co n t rol
strat eg y. T able 1 s umm a r i s e s th e sc en ari o desc riptio ns to ac compa ny th e de s c r ip tion s b e low.
Table 1. Scenario Descriptions
Control strateg y Scenario description Details
Ca sual
p a r t ne rs hi p
reduc t i o n
High
Plausible
Lo w
50% of age nts c ea s e ca sua l par tne rshi p s
50% of agents cease 50% of casual partnerships, ie.,
50% of such opportunities still happen
50% of age nts c ea s e a sma ll % (20 %) of c a s u a l
partn er s hi p s
Vac cina t i on
programme
Lo w : 25 %
Plausible 50%
High : 75%
Spe ed o f va cc ine del ivery; % of hig hly a t - risk t arget
group tha t rec eive vac cin a tion by day 1 20
% who S elf-
isola te a fter
dia gnosi s
Lo w 11 %
Plausible 22%
High er 33%
Max imal 44%
% o f infec ted agen t s who heed ad vice to s t op all
sexua l con tac t when in fec tiou s (a f ter po t ential d elay
to real is e ow n c ase s ta tu s)
Not e: A ssumed up take o f vac cine is con s tant ( s am e numbe r of do se s deli ver ed da ily) ac cum ulating
to 50% of th e group o ffe r e d the va cci ne, by 120 da ys aft er vac cina t i on programm e s tar ts.
Scenario 1: Partner reduction
In thi s scena r i o, th ere i s a r educ tio n in th e pr op ortion o f s ex ac ts tha t ar e ca sual ( c asual me a n s no
ste ady pa rtne r to c on side r) o r conc urren t ( stra ys fr om a ste ady pa rtne r). A bou t 5 0% of Ame r ic an
MSMs s u rveyed i n 2022 r e ported b ehavi our t o re duce t h e ir s ex par tne r coun t in order to prev e nt
ca tching mpox 11 . It wa s u nclea r h ow to r eflec t thi s r epo rted b e havio ur chang e in a gent int erac t i on s .
We opt ed f or th ree d i f f e re nt in ter p re tati ons, en abling s en s i tivit y ana lysi s in the e valuation s o f a
partn er re duc t io n s t ra tegy . A max imal interp r e ta t io n is t h at 50% of all a gent s s t o pped all c a sual
and/o r s t ray ing sex during the o u t br ea k duratio n, w hic h is very mu ch li ke our sel f -i sola tion sce na rio s
(below ) s o we d o n’t mod el thi s max imal interp r e ta t i o n a s par t of Sc en ario 1. A not her po ssible
interp re tati on mig ht be if 5 0% o f a gent s consi s t ently r educe d t heir ca s ua l /st r a yin g p art ne r s hip c ount
by 50%, a nd the oth er 50 % beha ved a s n o r ma l. A mor e w ides pre ad but l e ss co n s i st ent p artn er
reduc t i o n stra tegy whic h we tr e a t a s our mos t p l au sible a nd p re fer r e d in terp r e t a t i on, cou ld be i f
ag ent s rand o mly reduc ed their c a su al/ st raying partn er s hip s by 50% (50% of suc h opport uniti es still
happ ene d) . A third po s sibili ty is tha t 50 % of a gent s beh aved a s normal , while ca sual / stray ing
partn er s h ip s re du ced f or 50 % of ag en t s , b ut t he reduct ion was s m all a n d ef f ected by random agent s
(80% of such event s stil l h appen ed but 2 0% d id not).
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
11 | Page
Scenario 2: Vaccination only
In thi s scena r i o, vac cin ation up tak e i s hig h a nd ef fec t i ve, bu t the re are no beh avio ur c hange s . T he
model a ssume s tha t th e vacc ination pro tec tion i s imme dia te but o nl y if rec eiv e d befo re ex po s ur e:
va cci nating a n alre a dy infec ted ag en t do es no t re duce s ub sequ e nt in fec tiou sne s s. O the rwi se, t h e
lev el of pr otec t i on fr o m vac cina tion in th e model s was s table (doe s no t de clin e over time ). Rec e nt
data indic a ted that a singl e va cci ne do s e ca use d 78% of r e cipi e nts t o be come i mm une to mpox
4 .
Vac cina t i on in th e mo del i s deli v er ed a s a s ing le do s e, t arge te d a t individual s w ho have the hig he st
risk o f c atching mpox.
Deci ding ho w many of our ag ent s should be of fer ed th e vacc ine w as a trick y dec is ion. Ac t u al o f fer in
Britain w a s pr obably t o only a bou t 15% of re s id ent MS Ms. W e e s tima t e 15% beca us e t he re wa s
alm ost 50% uptake t o tho s e o f f e re d, r ep ort e d as 55,00 0 firs t do se s o f the smallp ox vac cin e that
we r e admini st ered to MSM s in B ritain in the 4 month p eriod le ading up to 3 N ov 2 022
11 , whi ch
co mpare s t o a n e stima ted 75 4,000 Bri ti s h men w ho ide nt i f i ed a s ga y or bi sexu al i n 2 019 29 , an d an
unc lear numbe r o f B r i t i sh me n who i de nt ify as h ete ro sexua l bu t are a lso M S M s . O nly about 1 0% of
ag ent s i n our ba s eline mod el fini s h w ith z e r o pa rt n e rs over a t hre e we ek mo nito ring period. Thi s
co mpare s t o a bout 35% of > 20 00 gen era l popul ation MSM s in a Sep tembe r 20 22 sur vey
30 w ho
repor ted they had ze ro par tne r s in the pr ece ding thr ee w eek s . How ever, r eal wor ld pa r tn er c ount s
repor ted by M S M s i n 2022 may ha ve be e n muc h dimini s hed bec a u s e o f conc urren t mp ox aw arene s s
(rea l l ife scen ario 1 dec i s i on s), ma king t h e real -wo r ld s urve y par tne r co unts al s o u n r ep re sent ativ e o f
unc ontr ol l ed beh a vioural pre fe r e nce s. We c ame to the pra gmatic deci s ion t h at i n our pre fe rred
bas elin e mod el, abou t 30% of our ag ent s (tho se at hig he s t ri sk) w ould be o ff ere d the va cc ine. W e
va r i ed the p ac e o f de livery , howe ve r, suc h that t he acc umula ted d elive r y was 25% , 50% or 75% of
targe t popu la tion by day 120 of stra te gy imp lementa tion . W e d eemed a s mo s t pl a us i bl e scena r i o ,
that 50% of the g r oup of f e r e d th e va cci ne had uptak e b y day 120.
High risk i ndividu al s were d e f i ned a s ag e nts w ho a re A ) s till su s c ep tible and B ) e i the r / both amo ng
the a gen t s with hig he s t sex app eti te a nd / or a gen t s with hig he s t tend e ncy t o pr a c tic e par tner
co ncurrency ( s t rayi ng at tribu te; some ag ent s w ere in b o t h group s). The se hig h r i sk agents rece ived
at rand om a single s ma llp ox vac cina t io n. This mea n f or in sta nce, wher e 50 % we r e vac cina t e d by d ay
120, that 39% of the en tir e hig h ri s k targ et group w ould no long er be s u sce p t i ble to mpox , bec au se
of th eir vacc inatio n. In prac t i ce, b ecau s e the mod el s tar t e d with e xac t l y 6400 agen ts, th e hi gh ri sk
group ten d ed to numb er a bo ut 1920 a nd the numb er who should b e e ff ectively p r otec ted by
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
12 | Page
va cci nation if 50% de livery ta r g et ach ieved af ter four mon th s w a s abou t 749 (~39 % of 1920): w e
monitor ed mo del pa rame te rs t o mak e su r e thi s ou t c ome w a s ach ieved .
Scenario 3: Some self isolation
We have no t foun d data d e scribi ng ac t u a l adhe r e nce to sel f -i sola tion adv ic e a ft er mpox diag nos i s in
2022 in the UK. 44% of Du tc h MSM s s ur vey ed in J u ly 202 2 31 indic ated hig h will ingnes s t o se lf -
isola te i f t h e y had mpox, at lea s t until a ll lesi on s were gone . G iven t hat st at ed int ention s t o co mply
wi t h public health a dvic e tend to be muc h s t ronger than a c tual compli ance 32 , t h e percent ag e o f
per son s w ith co n fir me d mpox diagn o s i s who have actual ly full y sel f-i so lat ed ha s probabl y bee n
muc h lowe r t ha n 44% . In sen si tivity anal y s is we te s t ed t h e s c enari os whe r e ei the r 11%, 22%, 33% o r
44% of infec tiou s agen t s iso lat ed af te r th eir sympt oms s t a rt. W e cho s e 22% as th e mos t plau sible
va lue. How ever, sel f -i sola tion st art wa s as s um ed to o ft en be del aye d to r efl ec t l i kely dela yed
recog nition /acc e ptanc e of ow n ca se st at us . Fo r tho se who s e lf -i sola te a t all, del a y t o s t art se lf -
isola tion fol low s a g amma d istribu tion (l ong right tail ) a f t e r fi rs t s ig n s o f inf ectio n , median delay i s
abou t 7 2 hour s, and rang e 0 to 40 0 hour s . Othe r a gent s don ’t sel f -i s ol a te at all when infec tiou s.
Results
Tab le 2 show s mode l targe t s and v alue s ac hieve d, with r eg ard t o age nt b ehavi ou r s a nd outcome s .
The model a chie ved mo st o f th e be h aviours an d a gent s ha d qua liti e s con sis ten t with the mod el
design objec tive s . Table 3 show s out bre a k ou t c ome s (media ns a nd I QR s) fo r the b a seli ne and
pref err ed al tern ative scena rio s. T able s S 1-S 4 in S uppleme n t a r y Mate rial show ou t b r e a k outc ome s
va r y ing e pidemiol ogic parame te r s with e ac h of th e candi da te con trol st r a te gy a ss umption s.
Monito ring o f mode l be haviou r, p aram et er a s s ig nment s and som e outc ome s all i n dica t e t h a t th e
model s p e rforme d a s d e s ig ned . F or in sta nce (T abl e 3) 67% of a gen t s are s t rong ly in contac t clu ste rs,
so t hey w ill tend to encou n t e r the s am e other age nts mo st commo nly. Simila rly , inc ubation p e r i od s ,
recovery/in fec tiou s pe riod s an d o ther p a ramet er s ar e a s s ig ned to a g ent s on the d esi red
dist r i buti on s (T abl e 1 ) . The medi an n um ber of p art ner s i s 1 in mos t s imu latio ns , whil e the
tran s m i ssion c hain s (co un ts o f ge ner atio ns in th e mpo x outbr eak ) ar e < 10 con si s t e nt l y (T abl e 3) .
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
13 | Page
Table 2. Verifying model performance in baseline scenario: stochastic
assignments
Parameter Tar get s:
Distribution
Range
Mean or median
Values realised in
baseline model runs (no
control strategy)
Inc ubati on pe r io d (day s ela p sed f r om
ex pos ur e t o s tar t of in fec t i ou s p er i od) o f
ag ent s
L og Normal 33
Ran ge: 3 -21 days 6,33-35
Medi an: 8 6,33,34
Rang e: 3.4 -21. 1
M e d i a n: 8. 5
Inf ec tiou s pe riod ( day s du rati on) o f agen ts
Normal
Ran ge: 7 - 2 8 day s
35
Mea n: 20 -21 da ys 36
Rang e: 10 -30
Mean: 20.xx x
S ex u a l a p p e ti t e ( fo r s e x ac ts pe r w ee k)
Gamma
15,2 0
Ran ge: > 0 t o 32 15,20
Medi an: 3 -6 37
Rang e: 0.2 – 29 .5
M e d i a n: 4. 3
% of agen ts wi t h a pr e fer r e d par tne r
(“st eady ”)
60 - 7 0%
21,38 Rang e: 64 -65
Median : 64 .4
Inc linatio n t o try part n e rs no t one ’ s st ea dy,
“str ay.thr e shold” a s % risk pe r oppo rtuni ty
Gamma 39,4 0
Ran ge: 0 -10 0
Medi an: 10 -12
Rang e: 0 -100
Median : 10 .5
In a dditi on to be h aviour ou tc ome s, Tabl e s 3 and S 1 -S4 repo rt t he k ey epi demic ou tcome s unde r
pref err ed plau sibl e ba selin e and c ont r ol s c en ario a s sumpti on s: ou tbr e ak dura tion and tot al c as e s
gen era ted a ft er s i mula tion sta rt for ba se l ine a nd unde r s ome pla u s ib l e co nt ro l s tr ategy
imple menta tion s . In Ta ble 3, re ducing ca s ual enco unte rs par tne r co ncurr ency (Sce nario 3, 5 0% of
such i ncide n ts don’ t ha ppe n) le a d s to th e most i mpr oved (l ow e s t ) c ount o f s econ da r y ca ses and
re sult s in t h e s h orte st du rati on, f rom me di an 83.4 days (ba seli ne ) t o 55.5 da y s. T he s c e nario that i s
nex t be s t a t r e ducing new ca se s i s when 2 2% of a gent s s e l f i s o la te a fte r inf ec tiou s period st a r t s (65
day duration o utbr eak ) . The vac cina t i on s c en ario ( d e livery to 50% o f most hi gh ri sk 30% of target
group) pro duc ed ne gligi ble impr ove ment s over ba s eline , from 83.4 to 8 0.5 da y s a nd alm ost no
reduc t i o n in new ca se s (17 t o 16 medi a n) . The s e n s i tivity ana ly se s ( T a ble s S1-S 4 ) sup por t the
primary r e sult s .
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
14 | Page
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
15 | Page
Table 3. Model performance and outbreak outcomes observed in each simulation, under baseline conditions and plausible control
strategies; without sensitivity analysis
Out break O utc omes Baseline
Ta r g et
Baseline
media n: IQ R
Par tner reduction
media n: IQ R
Vacc ination
median: IQ R
S o m e s e l f - is o la t io n
median: IQR
D u r at i o n of o u t br e a k f r om s eed i n g t o f inis h
day s
week s
no ta r g e t
83.4 : 62.2 -118 .1
13.9 : 8.9 -16.9
55. 5: 43.1 -72. 5
8.9 : 6.2 -10.4
80.5: 61-104
11.5: 8.7 -14.9
65.0: 49 -8 7
9.3 : 6. 9-12 .4
Number o f add i t i onal a ge nt s in fect ed
(s econda r y ca ses ) by time ou tbre ak fi ni she d
no ta r g e t 17: 10-29 8: 5 -12 16: 1 0-25 11: 6-18
Model perform ance metr i cs
% of s e x ac t s w ith the pr ef erre d par tne r
% of casu al sex ac t s (no st eady fo r initia t or)
% of s e x ac t s in s pit e o f havi ng a st eady
> 50%
no ta r g e t
no ta r g e t
64% : 54-73%
29% : 19-40%
6.7% : 4.8-8 .8 %
79% : 70-86%
17% : 9-26%
4.0 %: 2.1-5 . 9%
62% : 52-72%
31% : 20-42%
6.3% : 4.4-8 .5%
63%: 5 1-74%
30%: 1 7-44%
6.3%: 3 .8-8 .9%
Media n # uni q ue pa rtne r s dur i ng inf ec tio us
period ( ~3 we ek s)
1 1: 1 -2 1: 1 -1 1: 1-2 1: 1-1
Max imum # u nique pa rtner s du ring i nfec tiou s
period (~ 3 wee k s)
≤ 24 8: 4 - 1 2 3: 2 -5 7: 4-12 5: 2-9
#s exa ct s (p er agen t) duri ng infec t io u s pe r io d
(~3 w eek s lon g)
Media n 3 -6
Max . 32
5: 3 -6
19: 14-26
6: 4 -8.5
19: 14-26
5: 3. 5-6
18: 1 3-24
3: 2-5
15: 10-21
Le ngth tran s m i ssion c hain (c oun t of ag e n ts
inc luding but not be fo re se ed s, only cou nted
for age nts inf ec t ed af te r s eeding )
Media n ≤ 3
Max . < 10
1: 1 -2
4: 3 -6
1: 1 -1
2: 1 -3
1: 1-2
3: 2-5
1: 1-2
3: 2-4
Not e: A ssumpti on s and conditi on s fo r ba selin e and w ith judge d t o be mo st plau si ble ver sion s of con trol s tr a t e gie s a s de scr ibed in text . 1 000 simula tio n s ea ch .
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
16 | Page
Table S1. Sensitivity Analysis for Baseline scenario starting with 8, 16, 32 or 64 agents
Simul ation O utc omes
Median: I Q R
8 cases at star t
6 x 1000 simulations
16 cases at star t
6 x 1000 simulations
32 cases at star t
6 x 1000 simulations
64 cases at star t
6 x 1000 simulations
8, 16, 32, 64 agent s
24,000 simulations
Dura tion o f outb reak fr o m
se eding to fini sh day s
we eks
66.0: 39-141
9.4: 5.6 -20.1
97.3 : 53-207
13.9 : 7.6 -29.7
132.0: 6 7-267
18.9: 9. 6 -38.1
170.0: 81-312
24.3: 1 1.5 -44.6
99 . 2 : 5 2 -23 4
1 4.1: 7-33
Number o f add i t i onal a ge nt s
infec t ed ( se conda r y ca se s ) by
t i m e o ut br e ak f i n is h e d
8: 2-36
22: 6-103
56: 13-23 2
122: 28 -476
2 8: 6-173
Not e: Val ue s a re median : I Q R . 6 t ran s m i ssion r ate risk s pe r enc oun ter are : 6% , 12%, 24%, 36%, 48% or 6 0%. 1000 simul ation s wer e run f or ea ch o f th e se 5 opti o ns in th e
bas elin e s c en ario condi tion s.
Table S2. Sensitivity analysis for partner reduction scenarios (1), starting with 8, 16, 32 or 64 agents
Simul ation O utc omes
Median: I Q R
8 c as e s a t s t ar t
6 x 3 x 10 0 s i mulations
16 cases at s tar t
6 x 3 x 100 simulations
32 c ases at s tar t
6 x 3 x 100 simulations
6 4 c a se s a t s t a r t
6 x 3 x 1 00 simulations
Dura tion o f outb reak fr o m s e e ding
to fini sh days
wee ks
45.0: 3 4-72
6.5: 4.9 -1 0.3
58. 0: 40-93
8.3 : 5.8 -13.4
73.7 : 49-118
10.5 : 6.9 -16.8
89.1: 60-146
12.6: 8.6 -20.9
Number o f add i t i onal a ge nt s
infec t ed ( se conda r y ca se s ) by time
outbr eak fini sh ed
4: 2-9
9: 4-22
19: 8-44
41: 17 -96
Not e: 5 v alue s te sted for r i sk o f t r an smis s i on p er enc oun te r are : 6% , 12%, 24%, 36%, 48% or 60 %. Pl eas e s ee mai n text f o r de sc riptio n of pa rt n e r redu ction o ption s (n =3) .
100 s imu lati on s were run for ea ch pe r m uta t i o n and a re pool ed fo r thi s ta ble.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
17 | Page
Table S3. Sensitivity analysis for vaccination delivery rate scenarios (2), starting with 8, 16, 32 or 64 agents
Simul ation O utc omes
Median: I Q R
8 c ases a t s tar t
6 x 3 x 100 simulations
16 ca s es at st a rt
6 x 3 x 100 s imul at i ons
32 c ases a t s tar t
6 x 3 x 1 00 simulations
64 cases at st ar t
6 x 3 x 100 simula t ions
Dura tion o f outb reak fr o m
se eding to fini sh day s
we eks
63.5 : 38-121
9.1: 5.5 -17.3
8 7 . 3 : 5 1-15 7
12.5: 7.4 -2 2.4
116.0 : 65-195
16.4: 9.3 -27.8
27 1.4: 234 -323
38 .6: 33.5 -4 6.1
Number o f add i t i onal a ge nt s
infec t ed ( se conda r y ca se s ) by
t i m e o ut br e ak f i n is h e d
7 : 2-29
19: 6-65
46: 1 3-144
50 4: 401-63 6
Not e: V alue s ar e median : I Q R . 6 tr a n s mi s sion r ate risk s ar e: 6% , 12%, 24%, 36%, 48% or 60 %. 3 vac cina t i on roll out ra te s are: 25 %, 50% or 75% of ta rget po pul ati o n by d ay
120. 100 simul ati on s were run for ea ch permuta tion .
Table S4. Sensitivity analysis for self isolation scenarios (3), starting with 8, 16, 32 or 64 agents
Simul ation O utc omes
Median : IQ R
8 ca s es at st a rt
6 x 4 x 10 0 s i mulations
16 cases at s tar t
6 x 4 x 100 simulations
32 c ases at s tar t
6 x 4 x 100 simulations
6 4 c a se s a t s t a r t
6 x 4 x 1 00 simulations
Dura tion o f outb reak fr o m
se eding to fini sh days
week s
48.0: 3 4-83
6.9 : 4 .9-11 .9
62. 5: 40-115
9.9 : 5.7 -16.5
86.3 : 53-147
12.4 : 7.6 -21.1
107.0 : 63-184
15.4: 9.0 -26.3
Number o f add i t i onal a ge nt s
infec t ed ( se conda r y ca se s ) by
t i m e o ut br e ak f i n is h e d
4: 1-13
9: 3-33
26: 8-75
59: 15 -159
Not e: 6 tr an smission rat e r i sks are : 6% , 12% , 24% , 36% , 48% or 60%. 4 proportion s o f popula tio n th at s e l f i s o la te a ft er illn e s s on se t: 11% , 22%, 33% or 4 4%. 100
simula tion s w er e r u n fo r eac h pe rmuta ti on.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
18 | Page
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
19 | Page
Discussion
All of t h e s tr ategi e s c onsi der ed in o ur m odel s (pa rtn er r e duction , v acc ination , s e l f- i s o la t i o n af ter illn e ss on se t) could
be v ery ef fec t ive to sto p mpox outbre aks if de ployed fully. H ow eve r, rea li ty is tha t beh aviour c ha nge or vac cine
uptake i s o fte n imper fec t an d take s t ime to impleme n t . With re s p ec t to ou tbr eak duration a nd new c as e s a fte r
simula tion s ta rt, un der pla us i b le a s s u mp t i on s , our mod ellin g sugge s t s tha t red uc ing part n e r conc ur r enc y a nd ca s u al
partn er s hi p s w er e likely t o have had the most b ene fi ts in r edu cing mpox spr ead ( sce n ario 1) . I t m ay be s urp ri sing
that smallpo x va cc ination h a d negli gible ef fect s on o utbr eak lengt h a nd to tal num be r of sec ondary in fecti on s in o ur
model ling ( sce na rio 2) . T his fi nding l ikely aro se bec au se of the pa c e of v acc ine d e l ivery : only 50% a dministe r e d to
targe t group a fte r fou r m ont h s (in r e a lity an d in the mo del s ) . Fa s ter vac cin ati on d eli very w ould ha ve ma de th e rea l-
world vac cina t i on s tr ategy more ef fec t i ve. Fre e text c ommen t s abou t mpox col lected a s par t of a 202 2 sur v ey o f
MSMs in the UK
30 indi cated t ha t many r esp onden t s we r e f ru s tr a t e d abo ut or h a d encou nte r ed many di fficul tie s in
obtaini ng a s mal lpox v acc ine.
Se lf - i s ola t i on ( s c enario 3 ) was muc h mor e bene f i cial th an va cc ination , bu t le ss e f f ec t i ve than r e duc tion s in c a sual
partn er s h ip s ( sce nario 1 ) in our model s . Info rmatio n abou t ac t u al sel f -i s o la tion a dh er e nc e b ehavi ou r when
infec ti ou s during th e mpo x epi demic is st ill e merging. Given t he well docume n t e d cha llenge s ma ny pe ople h a d in
adhe r i ng t o s elf -i s o la tion r equir emen t s d uring t he C ovid1 9 pande mic
32 , a dher enc e t o mpox sel f -i sola tion
recom menda tion s seem s like ly to h a ve b ee n low , pe rhap s much lower th an our b as eline choic e o f 22% . Howe ver,
bec au se cl o s e con tac t i s g ene rally requi r ed to t ran smit mpox , th e s elf -i s ol ation u ndert aken in re a lity may hav e been
ade qua te i f not i d eal: pe ople r ef rain ed from physica l contac t alth oug h they di dn’ t s el f - i sola te in th eir home s en t ir el y.
The W o r ld H e alth Or g aniza tion al e r t ed gl obal auth oriti e s t o the 2022 mpox outbr eak in l ate M ay 2 022
41 . The
model ling h er e p rovide s ev idenc e fo r a c ommon hy pot h e s i s 42 that t he pe a k in case c oun t s (e s timat ed Jul y 9 i n U K 43
not long af te r thi s anno unc emen t and ca se c oun t dec lin e sinc e, should be cr edit e d mostly to b ehavi our choic e s by
membe rs of the MS M communi t y rath er than va cc ination p rogramm e s. Inde ed, smal lpox v acc ination t o MSM s a t
hig h ris k of ac quiring mpo x in the U K was not wi dely o ffe red be for e ea rly July 20 22
4 . Our modell ing ma y be h elp ful
in c onfirming t h e like ly v aluabl e con tribu tion t ha t pe rsonal beh av iour cho ice s hav e made and c an c on tinue t o ma ke
in b r ing ing mp ox outbreaks u nde r contr o l. T he importanc e of p er sona l be havi our choic es can b e vita l to s h a r e in
publi c hea lth ca mpaign s . T his s t atem ent i s not i n t e nd ed to und e r mi n e the hug e v al ue of v acc ina tion p r og r a mme s ;
va cci nes can con fer la sting immunity a nd resi stanc e to di sea s e, a nd thu s are a mo re r el i able popul atio n p r ot ec tion
mea s u re t han r e lying on indiv idual b eha v iour choi ces . Pr otec tiv e s exua l behav io ural c hoic e s are of ten no t su s tain e d
ove r long time pe riod s
44 . O n going s mal l pox v acc ination for B r iti sh MS Ms wa s su gge s t ed a s a key rea so n the re wa s
no l arge re su r g ence in new mpox cas e s i n the UK i n 2023 45 .
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
20 | Page
Se ns i tiv ity ana ly si s (Tabl es S1 - S 4 ) whi ch al lowed fo r dif fe r e n t number s o f inf ect e d agent s at b as elin e (8, 16, 32 or 64)
and dif fer ent t ran s mi s s i on ri s ks ( from 6 - 60% per c ontact ), do no t chang e th e ov e rall find ing t hat r educ ing c a sual
partn er s h ip s w a s rela tive ly more e ffe ctiv e as a epid emic cont rol ac ti on than v acc i nation o r s elf -i sola tion b ehavi our.
Howev er, comp ar ed to the ba s eli ne and p lausi ble a l ter n ative sce na rio s , ou r large r simula tion s e t s hav e wid er
interqu ar tile r a ng e s fo r t he key epid em ic ha r m outcome s: a ddi t i o nal c a se s a nd du ration o f th e out br e aks . Highe r
unc ert a inty abo u t e pid emic prot ection, e s pe ci al ly ov er a long er time peri od, can b e ex pected to a ssoci a te mor e wi t h
beha vioural stra tegie s ( par tner reduc t i o n or s om e sel f - i s ol a t i on ) tha n wi t h vac cina t i on .
Limitations
and Strengths
It wa s n ot fe a s i bl e to t e st ou r model s aga inst rea l world d ata . We a r e unawa re o f any r e al w or ld s itu a t io n that we
co uld co mpare wi t h, whe re on ly one o f t he s t ra teg ie s d es c ribed h ere wa s appl i ed to co nt rol mpox in MSM s in 2022.
We al s o no te t h a t a mpox epide mic w oul d not l a s t pe r pe tua lly i n a c lo s e d s y stem model such a s t hi s one ; the re i s
some po s s i bili ty tha t de pl etion o f th e mo s t a c tive susc eptib l e popula t i on al s o hel p ed to ha s ten th e de clin e of mpox
ca s e s in B r i t a in in 2 022 .
Model s ar e simpl i fie d ve rsion s of a c omplic ated a nd com pl ex w orld. Our model s c ons i d er a re lativ ely sex ually activ e
popul ati on; in re a lity, a la rge nu mber o f people have rela tive ly low cou nts of sex event s and p a r tn er s in th ei r l ive s
(low er tha n our mod el s sugge st
30 ). Po s t - e xpo sur e small pox vac cina tion i s though t to o ff er some pr otec tion agai n st
dev eloping inf ec t i ou s i lln e ss; ou r m od el s don’t all ow for t his p ossi bil ity. W e de s ig ned our mode l s to re fle c t plau sible
beha viour bu t la ck inform ation to c onfi d ently k now h ow repre s ent ative all o f th e se ma ny beh a viour a s sumptio ns
we r e of mo s t MS Ms in Br i t a in or el sewh e r e . For in stanc e, alt houg h we modelle d vac cine deploy ment a t a sp ee d in
ac cordanc e w ith publi sh ed i n f o r ma t io n a bout th e a ctual U K p rog r a mme, we did n ot c on sider i f beh a viour c hange
wa s i tsel f a l s o slow ly i mplemen ted . It i s possibl e t h a t chan ge in beh avi our in Eng land w as much s low er t han our
model s a ssum ed, a nd a s a r e sult n eith er sel f -i sola tion no r p a r tn e r r educ tion b ut r athe r oth er unme a s u red fa cto r s
we r e r e s p on sible for t h e decl in e in new E nglish mpox ca s e s a ft er J uly 2022.
Our model s a tt empt to ex amine e ach s t r ategy in isol atio n a nd doe s no t c on s id e r poten tial synergi s tic e f fect s . Nor d o
we allow for varyi ng impl emen tati on of a ny sce nari o. F or in stanc e, in re ali ty, the vac cina t i on progr amme l ikely had a
slow sta rt, the av era ge pa ce o f delive r y at s t a rt of p e r i od wa s slowe r tha n by the e nd, bec au se in fra s t ruc t u r e t a ke s a
little w hile t o cre ate . The c on s tan t ra te of vac cina t io n d eliv ery tha t our mod e l s a pplied will have s lig h tly ov er-
es timat e ra ted o f e a rly dos e de livery.
Our appr oac h i s novel in tha t we ar e not aw are o f oth er AB Ms t h a t addr es s mp ox spre ad amo ng MSM s . ABM s can
be rel a tively more f lex ible a nd na tur alis ti c compared t o o the r modelli ng appr oac h es
46 , expl icitly inco r po rating
hete roge n eity of a g ent a tt ribut e s and be ha viour c hoice s 47 . ABM s ar e de signe d t o revea l eme rge nt p henome na 46
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
21 | Page
and t hu s ma y provid e nove l in sight s to e pidemi c dy namic s . Our model s in h er e n tl y inc orpor a te d a s s or tive mixin g
whi ch is a well -rec ogni sed fea t ur e of ac t ual s oc ial n etworks 48,49 , possib le c onta ct rate s a nd pl au s i ble b eha viour
ch oices . We u s ed pu bli shed in forma tion t o cons tr uc t all o f t he con trol sce na rio s , t w o of th e scen ari o s e mulat ed
publi s h ed da ta ab ou t par t ne r count r edu c t i on s a nd va cci nation d el ivery. The s e ABM a dvant ag e s come with a pr ic e
in tha t the y are c ompu ta tional ly ex hau sti ve
47 and with our so ftwar e pl at fo r m, me ant tha t th e a gen t popul a tion
nee de d to be r e st r i cted (to 640 0 age n ts) to gen era te many s t rat egy and sc en ario outcome s i n a re a sonabl e
timef rame .
In rea li ty, MSM s in c ommuniti es a f fec t ed by mpox in 2022 d oubtle ss unde rtook a ble nd of b eha viour c hoic e s tha t
help ed t o reduc e tr a ns mi s sion . We h a ve not tri ed to e s tima te what the op tima l mix of multiple s tr at egie s w ould be .
Clea r l y, c ombined str at egie s are mo r e e f fective than any st r at egy in isola t i on; d e ploy ing a variety of con trol
strat eg ie s f or a ny fu tur e mpox outbre aks is c learly wis e in th e r ea l wo r l d.
References
1. ECD C. F act sh ee t fo r heal t h pr o fe s sio nal s on mpo x (monkeypox ). Jun 1 20 23.
http s : / /www .ecdc .eur opa. e u / en /all - top i c s-z/monkey pox /fac t she et -hea lth -pro fe s s ion a ls
(acc e ssed Jan 5 2024 ).
2. Sk lenov s ká N, Van R an st M . Eme r g ence o f monkey pox a s the mo s t i mportan t o rth opox virus In fec tion in
huma ns. Fr ont ie rs in Pu b l ic H e a lt h 2 018; 6 .
3. Pola nd GA, Kenn edy RB, To sh PK . Preve n tion of monkey pox w ith va cci nes: a r apid r ev iew. The Lanc et
Inf ec tiou s D is e a s e s 202 2.
4. Maha se E . M onkey pox: S ingle do se o f sm allpox vac cin e off er s 7 8% protec tio n, UK H S A r e port s. Bri tish
Medic al Jo urn al 2022; 379 .
5. Rey nold s MG , Da mon IK . Out bre aks o f h uma n monke ypox afte r ce s s a t i o n of smal lpox vac cin ation. Trend s
Mic r ob iol 201 2; 20 (2 ): 80 -7 .
6. Thornhil l J P, Barka t i S, W alm s l ey S, et al . Monk eypox virus in fec tio n in hum an s acr os s 1 6 coun trie s— A p r il –
June 2 022. Ne w E n g l an d Jo u r na l of M e dic i n e 2022; 387(8): 679 - 9 1.
7. Pat el A, Bilin ska J, Tam JC , et al . Cl inic a l f eatu re s and no vel p re sen ta tion s of hum a n monkey pox i n a c entral
Lo ndon ce ntre dur i ng th e 20 22 outbr eak: de scriptive ca s e s erie s . Br Med J 202 2; 378.
8. Sa h R, Mohan ty A, Abd ela al A , Red a A, R odrigue z-Mo rale s A J, Hen ao -Mar tine z AF . F irst Monkey pox d eath s
out side A frica : no ro om for com plac e ncy. Therap e ut i c Ad v a nce s in I nf ectio u s D ise ase 20 22; 9 : 20 4993612 2112402 7.
9. Voge l L. M a king s en se of monkey pox de a th rat e s . Ca n Med As soc J 20 22; 15 ( E 10 97 ) .
10. Sa mara s e ka ra K, Rings hall M , Para sh ar K, et a l. Cont ributi on of me n who h ave s ex with me n (MSM )
att ending due t o c ontac t trac ing t o the d i agnos e s of H IV, syphili s an d gono rrho ea i n MSM from a c linic -ba sed
popul ati on. Se xuall y Trans mit ted In fe ctio ns 2022 ; 98 (4): 307 - 9 .
11. Delan e y KP. St r a te gie s adop ted by ga y, b isex ual, a nd oth er men w ho hav e sex w it h men to p r e ven t
monkeypox virus tr a n s mi s sion —U nit ed S tat e s , Augu st 2022. Morb Mortal Wee kly Rep 202 2; 71 .
12. Coon ey C, Du rbin A. Hig h -r i sk monkey po x c ontacts a dv is e d t o i s o la te . BBC New s. 20 22 23 Ma y.
13. Wellma n M P. P utti ng the agen t i n age n t - ba sed modeling . Au ton omo u s Age nt s a n d Mul t i -A ge n t System s
2016 ; 30 (6): 11 75 -89.
14. Pit t R, F o s t er C , Ra yment M , e t al . P13 2 L ow preval ence o f a symptoma tic Mpox v irus i n men a t t endi ng sexua l
hea lth s e rv ice s in E ngland . UK Heal th S e curity Ag ency Annual M ee t i ng,; 202 3; Le eds U K : B M J Pu bli shing Gr oup L t d;
2023 .
15. Endo A, Mur a yama H, Abbo tt S, e t a l. H e avy -t a ile d s exu al c ont a ct n etw or ks a nd monk e ypox epidemi ology in
the g lobal o u t br ea k, 202 2. Sc ienc e 202 2; 378(661 5): 90 -4.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
22 | Page
16. Sha lizi CR, Th oma s A C . H o mophily and c o ntagion ar e gene r ic ally con f o und ed in ob s e rv ation al s oci al ne t w o r k
s t udi es . Soc iolo gic al Met ho d s & Re searc h 2011; 40 (2) : 211-39.
17. Mac Car ron P , Ka s ki K, Dun bar R . C alling Dunbar' s number s. Soc ial Network s 2 0 16; 47 : 15 1-5.
18. Braina rd J, H un ter PR, H a ll I. An ag ent -ba sed mod e l abou t th e ef fec t s of fake n ews on a no roviru s outb r e ak
Rev Epide miol S an te P ub li que 2020; 68 (1 ) : 99-107 .
19. Mos s o ng J, Hen s N, Jit M, e t al. S ocial co ntac t s a nd mix ing pa t t ern s r eleva n t t o t h e s p rea d o f in fec ti ou s
dise a se s. PLo S Med 2 008; 5 (3 ): e 74 .
20. Braina rd J, Pott s HW , Smith L E, Rubi n G J . T he relati on ship be tween age a nd s ex pa r tn er c ount s d u r in g the
mpox outbreak in th e UK, 202 2. ( und er rev iew) 2023.
21. Braina rd J, Smith L E, P ot ts HW, Rubi n G J . T he relati on ship be tween age a nd s ex pa r tn er c ount s d u r in g the
mpox outbreak in th e UK, 202 2. P L oS O ne 202 3; 18 (9): e 0291001 .
22. Pal M, M engs tie F, Kandi V. Epid emi olog y, diagn os i s, an d contr ol of mon keypo x d ise as e: a compr ehe n s iv e
revie w. Am J I n fect Di s Microbi o l 2017; 5 ( 2): 94-9 .
23. Cen ter s for D i sea se Co n t rol . Clinic al R ec o gnition: Key Ch a ract eri st i c s for Id enti fyin g Mpox. 2 023.
http s : / /www .cdc .gov/pox virus/mpox / c li nic ians / c linic al -recog ni tion .html
( ac ce ss e d May 17 202 3).
24. Adler H, Gould S , Hin e P, et al. C linic al fe atur es and ma nage men t o f human monkey pox: a r e tro spec tiv e
obs ervati ona l s tudy in th e UK. Th e La n c e t I nf e c t i ous D is e as es 2022; 22 (8 ): 1153-6 2 .
25. Manzulli V, Sci o s c ia G, Giga nt i G , e t al. R e al time P CR and cult ure -ba s ed vi r us i sol a tion t e st in c linic ally
recov ere d pati e nts: i s t he subjec t s till in f ectiou s f or SARS -Co V 2 ? J ourn al o f Clinic a l Medi cine 2021; 10 (2 ): 309.
26. Ježek Z , G r a b B, Szcz eniow s ki M, Pal uk u K, M u t omb o M. Hum an monkeypox : s econda r y at tack rat e s . Bu l l e t in
of t he W orl d H e al th Or g an izati on 1988; 66 (4): 465.
27. Be sombe s C , Mbre nga F, Ma laka C, e t al . Inves tigati on of a mpox ou tbre ak in Cen t ral Af rica n Rep ubl ic, 2 021-
2022 . On e Heal th 20 23; 16 : 100523.
28. Nolen L D , Osade b e L, Katomba J, e t al. Ex tende d hum an- to - h uman tran smi ssion d uring a mon keypo x
outbr eak in the Democ r atic Re p ublic of t he Congo . Emergi ng I nfec t i o u s Di se as es 2016; 22 (6): 101 4.
29. Offi ce f or N ation al Sta ti st i c s. S ex ual orie nta t i o n, UK: 2019.
http s : / /www .ons. gov.uk/ p e ople popula t i onandc ommunity/cul tur ali den tity/ sex ua lity/bulle t i n s/se xuali den tityuk /201
9 : Of fice for Nation a l Sta ti stic s,, 202 1 .
30. Smi t h LE, Potts H W , Bra inard JS, e t al. M pox know ledge , atti tude s, belie f s, an d in tende d behavi ou r in the
gen eral pop ul ati on and men wh o ar e ga y, bisex ual , a nd who have s ex with me n. medR xiv 2022.
31. Wang H , de P aul o KJdA , Gül tz ow T, Zi mmermann HM, Jona s KJ . Monkeypox se lf -di agnosi s abil i tie s ,
dete rmina nts o f v acc inatio n a nd sel f-i s o l ation int enti on a ft e r diagno si s among M SM, the Net herl and s, July 2022.
Euros urveil l ance 2022; 27 (33) : 220 0603.
32. Smi t h LE, Potts H W , Amlô t R, Fe a r N T , Mi chi e S, Ru bin G J. Adh er ence to the t e s t, t rac e, and i s o l ate sy s t em in
the UK: Re sul t s f r om 37 nation a lly rep re s enta tive surv eys . Briti sh M e dica l J ourn al 202 1; 372: n608.
33. Miura F , van Ewij k CE, Backer JA, et al . E stimate d incuba tio n perio d fo r monkeypo x ca s e s c onfi rmed in th e
Neth erla nd s, May 2022. Eu r o s u rv ei l l an ce 202 2; 27 (24): 2200448 .
34. Guz ze tt a G, Mammon e A, Fe rra ro F, e t al . E arly Estima te s o f Monke ypox Incub a t i o n Peri od, G ene rati on
Time , and R epro duction Number , It al y, May -J u n e 2022. Emer ging In fectio us Di se ase s 2022; 28 (10 ).
35. World He alth O rganiza tion . Mpox (monke ypox). 18 Apr 2023 . ht t ps :// ww w . wh o . in t / ne w s- r oom / f a ct-
she et s/de tail / monkeypox (ac ce s s ed 9 Se p t 2023).
36. Pra sad S , Ca sa s CG , S tr a h an A G, et al . A d ermatol ogi c as s e s sm ent o f 10 1 mpox (monkey pox) c as e s fr om 13
co untr ie s du ring the 2022 ou tbre ak: S kin l es i on mo rphology , cl inica l co urse , a nd sc arring. Jo u r na l of t he Am e r i ca n
Aca demy of D e r m at o l ogy 2 023; 88 (5 ): 1066-73.
37. Wellin g s K, Palme r M J, Ma chiy ama K, Sla y make r E . Chang e s in, a nd fac tor s a ssoci a ted wi t h , frequ ency o f se x
in Britai n : evid ence f rom thre e N a tion al Surv eys o f Sex ual A t tit ude s and Lif e style s (N a t s al) . B r i t is h Me d ic a l J o ur nal
2019 ; 365.
38. Mercer CH, J one s KG, Gea ry RS, et a l. A ss oci ation o f timin g o f s exua l part ner s hi p s a nd percep t io n s o f
partn er s ' Concu rrenc y wi t h r e p or tin g o f sexua lly tr an smitte d in fec t i o n diag no s i s. J AM A N e t w o r k O p en 2018; 1 (8 ):
e18 5957-e .
39. Sc ott N, S toové M , W il s on DP, et al . E liminating hepa titi s C v ir u s a s a pu blic heal th threa t a mong HI V- po sitive
men who ha ve sex with men: a multi-m o de lling a ppro ach t o unde r s ta nd dif fe renc es in s ex ual ri sk be h aviou r . J I n t
AIDS S oc 20 18; 21 (1): e25059.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
23 | Page
40. Romero -Se ve r s on E, Vol z E, K oopman J, L eitne r T, Ionid es E . Dy namic variati on in s exua l contac t r at es in a
co hor t o f H I V- neg at ive g ay m en. Am J Ep i demio l 2015; 182 (3): 255 - 6 2.
41. Or g aniza tion WH . Multi -coun try mo nkey p ox outbreak in non - en demic count rie s. May 21 2022 .
http s : / /www .who.in t/eme rge ncie s /di s e a s e -ou t br ea k-n ews /i t e m/ 20 22 - D ON385
(a c ces sed Dec 2 2022).
42. Kupfer schmid t K. Monkey pox c as e s are p lummeting . Sc ien ti sts ar e d eba ting why. 26 Oct 2022 .
http s : / /www .s c ienc e.org /cont ent / a r tic le /monkey pox-c a se s-a re -plum meti ng- scie ntis t s-ar e-d eba t i ng-why (acc e s s e d
Dec 4 2022).
43. Ward T, C h r i stie R , Pa ton RS, Cumming F, Overton CE. T r a n s mi s sion dy namic s of mo nkeyp ox in t he U n it e d
King dom: co nt a ct t racin g study . Br Me d J 20 22; 379.
44. She r ma n D W , Kirton CA . The exper ien ce of rel a p s e to unsa f e s e xual behav io r amo ng H IV -po sitive ,
hete ro sexua l, mino rity m en. Appl Nur s R es 1999; 12 (2 ): 91 -100.
45. Zha ng X-S, Mandal S, M ohamm ed H, e t a l. Tran smissio n dy namic s and ef fec t of co ntrol mea s u re s on t he
2022 outbre ak of mpox a mong ga y, bi s ex ual, a nd ot her men who ha ve sex with m en in Engl and: a math ematic al
model ling s tudy. T h e La n c e t I nf e c t i ous D is e as es 2023.
46. Bonab e au E. Agen t-b a sed mode l ing: Me t hods a nd t e chniq ue s f or simulatin g hum an s y st ems . Proce e ding s o f
the N ati onal Acade my of S cie nces 200 2; 99 (su ppl_3 ): 7 280-7 .
47. Molla J, S ekk ak I, Ortiz AM , Moyle s I, Na sri B. Ma the ma tical modeli ng o f mpox : A scoping revie w . On e H e a lt h
2023 : 100540 .
48. Krz y ż a nowska M, M a s c ie -Tay lor C N . Edu ca tional a nd soci al cla ss a s s o rta tive mati ng i n fertil e Bri ti sh coupl e s.
Ann Hu m Bi ol 201 4; 41 (6): 56 1 -7.
49. Phil lip s G , Bi rket t M, Hammond S , Mu s ta n s ki B. Par tner p re fer ence among men w ho hav e se x w it h men:
poten tial con tribu tion to spr ead o f H I V w ithin min or ity popul atio n s. LG B T h ea lt h 2016; 3 (3 ) : 225 -32.
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
24 | Page
. CC-BY-NC 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted February 6, 2024. ; https://doi.org/10.1101/2024.02.06.24302176doi: medRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.